Detalhe da pesquisa
1.
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial.
Ann Rheum Dis
; 81(10): 1392-1399, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701155